Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study - Top-Institutions - MDSpire

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study

  • By

  • Marta Codirenzi

  • Federica Davanzo

  • Luca Iorio

  • Eleonora Fiorin

  • Gabriella Guarnieri

  • Fulvia Chieco Bianchi

  • Alessia Achille

  • Maria Rita Marchi

  • Andrea Vianello

  • Andrea Doria

  • Roberta Ramonda

  • Roberto Padoan

  • June 15, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Padua University Hospital
    Padua University Hospital

    Padua, Italy

    Key Differentiators

    • Rheumatology
  • #2

    Padua Vasculitis Center
    Padua Vasculitis Center

    Padua, Italy

    Key Differentiators

    • Rheumatology
  • #3

    Jagiellonian University Hospital
    Jagiellonian University Hospital

    Cracow, Poland

    Key Differentiators

    • Rheumatology
  • #4

    IRCCS Ospedale San Raffaele
    IRCCS Ospedale San Raffaele

    Milan, Italy

    Key Differentiators

    • Rheumatology
  • #5

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

Original Source(s)

Related Content